21 May Pharmazac launched the new product Petasitis Hybridus (Petagran)
Pharmazac has developed in its laboratories and launched in the Greek pharmaceutical market a nutraceutical, the titrate extract of Petasitis Hybridus in liquid hard gelatin capsules of 70,4 mg P A free, under the trade name Petagran.
Petagran / Petasitis hybridus is effective in reducing the frequency and severity of migraine attracts.